$2.48
+0.00 (+0.00%)
Open$2.49
Previous Close$2.48
Day High$2.52
Day Low$2.45
52W High$7.82
52W Low$2.11
Volume—
Avg Volume799.5K
Market Cap137.40M
P/E Ratio—
EPS$-1.35
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+845.2% upside
Current
$2.48
$2.48
Target
$23.44
$23.44
$15.10
$23.44 avg
$28.04
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 193.62M | 202.51M | 206.29M |
| Net Income | -27,587,371 | -28,749,471 | -33,771,699 |
| Profit Margin | -14.3% | -14.2% | -16.4% |
| EBITDA | -51,862,975 | -48,122,998 | -52,884,989 |
| Free Cash Flow | -39,587,712 | -47,283,878 | -36,549,207 |
| Rev Growth | +24.4% | +2.2% | +1.5% |
| Debt/Equity | 0.26 | 0.22 | 0.30 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |